Emma Courtroom / Bloomberg:
TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yr — – TrialSpark expands from medical trials into growing medication — Firm raised $156 million, is valued at greater than $1 billion
[ad_2]
Source